Skip to main content
Log in

Disease severity in sibling pairs with type 1 Gaucher disease

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Abstract

The only prognostic markers in Gaucher disease, the most common lysosomal storage disorder, are young age at first symptom/sign and the presence of null/severe mutations, both being predictive of more severe phenotypes. Therefore, it would be helpful to know whether siblings with the same genotype can be expected to experience comparable phenotypic expression. All non-neuronopathic sibling pairs in our referral clinic (1993–2008) with the same genotype were included. For each pair, gender, date of birth, severity score index at presentation, age at diagnosis and first symptom/sign, presence of bone involvement, spleen status, and use of enzyme replacement therapy were tabulated. There were 90 pairs of siblings: two sets of identical twins; 24 pairs of brothers, 24 pairs of sisters, and 42 pairs of mixed gender. For all measures of disease severity used, only in sibling pairs with an older sister and a younger brother were phenotypes significantly different between siblings. Thus, this large cohort of sibling pairs with type 1 Gaucher disease confirmed that, in general, the phenotypic expression in the younger sibling will be similar enough to that of an older affected sibling that genetic counseling may use those findings in a prognostic way.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

SSI:

severity score index

ERT:

enzyme replacement therapy

References

  • Amato D, Stachiw T, Clarke JT, Rivard GE (2004) Gaucher disease: variability in phenotype among siblings. J Inherit Metab Dis 27:659–669

    Article  CAS  PubMed  Google Scholar 

  • Barton NW, Brady RO, Dambrosia JM et al (1991) Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher’s disease. N Engl J Med 324:1464–1470

    Article  CAS  PubMed  Google Scholar 

  • Beutler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Valle D, Beudet A et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3635–3668

    Google Scholar 

  • Elstein D, Abrahamov A, Hadas-Halpern I, Meyer A, Zimran A (1998) Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease. Q J Med 91:483–488

    CAS  Google Scholar 

  • Lachmann RH, Grant IR, Halsall D, Cox TM (2004) Twin pairs showing discordance of phenotype in adult Gaucher’s disease. Q J Med 97:199–204

    CAS  Google Scholar 

  • Levy-Lahad E, Zimran A (1997) Gaucher’s disease: genetic counselling and population screening. Baillieres Clin Haematol 10:779–792

    Article  CAS  PubMed  Google Scholar 

  • Ramsay SL, Maire I, Bindloss C et al (2004) Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases. Mol Genet Metab 83:231–238

    Article  CAS  PubMed  Google Scholar 

  • Whitfield PD, Nelson P, Sharp PC et al (2002) Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity. Mol Genet Metab 75:46–55

    Article  CAS  PubMed  Google Scholar 

  • Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E (1989) Prediction of severity of Gaucher’s disease by identification of mutations at DNA level. Lancet 2:349–352

    Article  CAS  PubMed  Google Scholar 

  • Zimran A, Elstein D, Kannai R et al (1994) Low-dose enzyme replacement therapy for Gaucher’s disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med 97:3–13

    Article  CAS  PubMed  Google Scholar 

  • Zimran A, Abrahamov A, Elstein D (2000) Children with type I Gaucher disease: growing into adulthood with and without enzyme therapy. Isr Med Assoc J 2:182–183

    PubMed  Google Scholar 

  • Zimran A, Morris E, Mengel E et al (2009) The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause). Blood Cells Mol Dis 43:264–288

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the considerable expertise and patience of Ms. Tali Bdolah-Abram of the Hebrew University who performed all the statistical analyses and who thereby enabled us to have a more cogent understanding of the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deborah Elstein.

Additional information

Communicated by: Ed Wraith

Conflict of interests: None of the authors had any conflicts of interest that might have affected this study or the results herein reported. No funding was received for this project.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elstein, D., Gellman, A., Altarescu, G. et al. Disease severity in sibling pairs with type 1 Gaucher disease. J Inherit Metab Dis 33, 79–83 (2010). https://doi.org/10.1007/s10545-009-9024-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-009-9024-7

Keywords

Navigation